Immortalized cell lines derived from mice lacking both type I and type II IFN receptors unify some functions of immature and mature dendritic cells

Immunology and Cell Biology

Volumn 77, Issue 2, 1999, Pages 153-163

  Nunez, R ^a   Grob, P ^a   Baumann, S ^a   Zuniga, A ^a   Ackermann, M ^a   Suter, M ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

Borna disease virus; Dendritic cell lines; Immune response initiation; Interferon receptor knockout

Indexed keywords

INTERFERON RECEPTOR;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIGEN PRESENTATION; ARTICLE; BORNA DISEASE VIRUS; CELL FUNCTION; CELL IMMORTALIZATION; CELL MATURATION; DENDRITIC CELL; HEMATOPOIETIC CELL; IMMUNE RESPONSE; MOLECULAR CLONING; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; PROTEIN PROCESSING; RECEPTOR BINDING;

ANIMALS; ANTIBODIES, VIRAL; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; BORNA DISEASE VIRUS; CELL LINE, TRANSFORMED; DENDRITIC CELLS; HYBRIDOMAS; IMMUNIZATION; INTERLEUKIN-12; INTERLEUKIN-6; LEUKOCYTES; MEMBRANE PROTEINS; MICE; RECEPTOR, INTERFERON ALPHA-BETA; RECEPTORS, INTERFERON; T-LYMPHOCYTES; UP-REGULATION; VIRAL PROTEINS;

ANIMALIA; BORNA DISEASE VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0032921315     PISSN: 08189641     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1711.1999.00806.x     Document Type: Article

References (49)

1. Katz SI, Cooper KD, Iijima M, Tsuchida T. The role of Langerhans cells in antigen presentation. J. Invest. Dermatol. 1985; 85 (Suppl. 1): S96-8.
2. Steinman RM. The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 1991; 9: 271-96.
3. Cella M, Sallusto F, Lanzavecchia A. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 1997; 9: 10-16.
4. Guzman CA, Rohde M, Chakraborty T et al. Interaction of Listeria monocytogenes with mouse dendritic cells. Infect. Immun. 1995; 63: 3665-73.
5. Moll H, Flohe S, Rollinghoff M. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response. Eur. J. Immunol. 1995; 25: 693-9.
6. Cameron P, Pope M, Granelli-Piperno A, Steinman RM. Dendritic cells and the replication of HIV-1. J. Leukoc. Biol. 1996; 59: 158-71.
7. Grabbe S, Beissert S, Schwarz T, Granstein RD. Dendritic cells as initiators of tumor immune responses: A possible strategy for tumor immunotherapy? Immunol. Today 1995; 16: 117-21.
8. Mayordomo JI, Zorina T, Storkus WJ et al. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity. Nature Med. 1995; 1: 1297-302.
9. Winzler C, Rovere P, Rescigno M et al. Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures. J. Exp. Med. 1997; 185: 317-28.
10. Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997; 388: 782-7.
11. Pierre P, Turley SJ, Gatti E et al. Developmental regulation of mouse class II transport in mouse dendritic cells. Nature 1997; 388: 787-92.
12. Steinman RM, Pack M, Inaba K. Dendritic cells in the T-cell areas of lymphoid organs. Immunol. Rev. 1997; 156: 25-37.
13. Sen GC, Lengyel P. The interferon system. A bird's eye view of its biochemistry. J. Biol. Chem. 1992; 267: 5017-20.
14. Balkwill F, Pitha PM. Interferons and cytokines on a grand scale. Cytokine Growth Factor Rev 1997; 8: 91-5.
15. Binder D, Fehr J, Hengartner H, Zinkernagel RM. Virus-induced transient bone marrow aplasia: Major role of interferon-alpha/beta during acute infection with the noncytopathic lymphocytic choriomeningitis virus. J. Exp. Med. 1997; 185: 517-30.
16. Moritz T, Kloke O, Nagel-Hiemke M et al. Tumor necrosis factor alpha modifies resistance to interferon alpha in vivo: First clinical data. Cancer Immunol. Immunother. 1992; 35: 342-6.
17. Huang S, Hendriks W, Althage A et al. Immune response in mice that lack the interferon-gamma receptor. Science 1993; 259: 1742-5.
18. Muller U, Steinhoff U, Reis LF et al. Functional role of type I and type II interferons in antiviral defense. Science 1994; 264: 1918-21.
19. Steinhoff U, Muller U, Schertler A, Hengartner H, Aguet M, Zinkernagel RM. Antiviral protection by vesicular stomatitis virus-specific antibodies in alpha/beta interferon receptor-deficient mice. J. Virol. 1995; 69: 2153-8.
20. Ortner U, Inaba K, Koch F et al. An improved isolation method for murine migratory cutaneous dendritic cells. J. Immunol. Methods 1996; 193: 71-9.
21. Sassano M, Granucci F, Seveso M, Marconi G, Foti M, Ricciardi-Castagnoli P. Molecular cloning of a recombinant retrovirus carrying a mutated envAKR-mycMH2 fusion gene immortalizing cells of the monocytic-macrophage lineage. Oncogene 1994; 9: 1473-7.
22. Lutz MB, Granucci F, Winzler C et al. Retroviral immortalization of phagocytic and dendritic cell clones as a tool to investigate functional heterogeneity. J. Immunol. Methods 1994; 174: 269-79.
23. Koch F, Trockenbacher B, Kampgen E et al. Antigen processing in populations of mature murine dendritic cells is caused by subsets of incompletely matured cells. J. Immunol. 1995; 155: 93-100.
24. Roehm NW, Marrack P, Kappler JW. Antigen-specific, H-2-restricted helper T cell hybridomas. J. Exp. Med. 1982; 156: 191-204.
25. Guery JC, Ria F, Galbiati F, Adorini L. Normal B cells fail to secrete interleukin-12. Eur. J. Immunol. 1997; 27: 1632-9.
26. Carbone KM, Rubin SA, Sierra-Honigmann AM, Lederman HM. Characterization of a glial cell line persistently infected with borna disease virus (BDV): Influence of neurotrophic factors on BDV protein and RNA expression. J. Virol. 1993; 67: 1453-60.
27. Thiedemann N, Presek P, Rott R, Stitz L. Antigenic relationship and further characterization of two major Borna disease virus-specific proteins. J. Gen. Virol. 1992; 73: 1057-64.
28. Sauder C, Muller A, Cubitt B et al. Detection of Borna disease virus (BDV) antibodies and BDV RNA in psychiatric patients: Evidence for high sequence conservation of human blood-derived BDV RNA. J. Gen. Virol. 1996; 70: 7713-24.
29. Schneemann A, Schneider PA, Lamb RA, Lipkin WI. The remarkable coding strategy of borna disease virus: A new member of the nonsegmented negative strand RNA viruses. Virology 1995; 210: 1-8.
30. Nygren PA, Eliasson M, Abrahmsen L, Uhlen M, Palmcrantz E. Analysis and use of the serum albumin binding domains of streptococcal protein G. J. Mol. Recogn. 1988; 1: 69-74.
31. Dudler T, Chen WQ, Wang S et al. High-level expression in Escherichia coli and rapid purification of enzymatically active honey bee venom phospholipase A2. Biochem. Biophys. Acta 1992; 1165: 201-10.
32. Crameri R, Suter M. Display of biologically active proteins on the surface of filamentous phages: A cDNA cloning system for the selection of functional gene products linked to the genetic information responsible for their production. Gene 1993; 137: 69-75.
33. Suter M, Butler J. The immunochemistry of sandwich ELISAs. II. A novel system prevents the denaturation of capture antibodies. Immunol. Lett. 1986; 13: 313-16.
34. Pauli G, Ludwig H. Increase of virus yields and releases of Borna disease virus from persistently infected cells. Virus Res. 1985; 2: 29-33.
35. Paglia P, Girolomoni G, Robbiati F, Granucci F, Ricciardi-Castagnoli P. Immortalized dendritic cell line fully competent in antigen presentation initiates primary T cell responses in vivo. J. Exp. Med. 1993; 178: 1893-901.
36. Lutz MB, Assmann CU, Girolomoni G, Ricciardi-Castagnoli P. Different cytokines regulate antigen uptake and presentation of a precursor dendritic cell line. Eur. J. Immunol. 1996; 26: 586-94.
37. DeMaeyer E, DeMaeyer-Guignard J (eds). Interferons and Other Regulatory Cytokines. New York: Wiley, 1988.
38. Billiau A. Interferon-gamma: Biology and role in pathogenesis. Adv. Immunol. 1996; 62: 61-130.
39. Pestka S, Langer JA, Zoon KC, Samuel CE. Interferons and their actions. Ann. Rev. Biochem. 1987; 56: 727-77.
40. Okamura HH, Tsutsi T, Komatsu M et al. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378: 88-91.
41. Heufler CF, Koch U, Stanzl G et al. Interleukin-12 is produced by dendritic cells and mediates T helper 1 development as well as interferon-gamma production by T helper 1 cells. Eur. J. Immunol. 1996; 26: 659-68.
42. Cousens LP, Orange JS, Su HC, Biron CA. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc. Natl Acad. Sci. USA 1997; 94: 634-9.
43. Rincon M, Anguita J, Nakamura T, Fikrig E, Flavell RA. Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells. J. Exp. Med. 1997; 185: 461-9.
44. Coutelier JP, van der Logt JT, Heessen FW, Vink A, van Snick J. Virally induced modulation of murine IgG antibody subclasses. J. Exp. Med. 1988; 168: 2373-8.
45. Bjorck P, Flores-Romo L, Liu YJ. Human interdigitating dendritic cells directly stimulate CD40-activated naive B cells. Eur. J. Immunol. 1997; 27: 1266-74.
46. Dubois B, Vanbervliet B, Fayette J et al. Dendritic cells enhance growth and differentiation of CD40-activated B lymphocytes. J. Exp. Med. 1997; 185: 941-51.
47. Tew GJ, Wu J, Qin D, Helm S, Burton GF, Szakal AK. Follicular dendritic cells and presentation of antigen and costimulatory signals to B cells. Immunol. Rev. 1997; 156: 39-52.
48. Lanzavecchia A. Understanding the mechanism of sustained signaling and T cell activation. J. Exp. Med. 1997; 185: 1717-19.
49. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science 1995; 268: 1766-9.